发明授权
US07517880B2 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
失效
使用对称和不对称二苯脲抑制p38激酶
- 专利标题： Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
- 专利标题（中）： 使用对称和不对称二苯脲抑制p38激酶
-
申请号： US10060396申请日： 2002-02-01
-
公开(公告)号： US07517880B2公开(公告)日： 2009-04-14
- 发明人: Scott Miller , Martin Osterhout , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood , David E. Gunn , Holia Hatoum-Mokdad , Marell Rodriguez , Robert Sibley , Ming Wang , Tiffany Turner , Catherine Brennan
- 申请人： Scott Miller , Martin Osterhout , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood , David E. Gunn , Holia Hatoum-Mokdad , Marell Rodriguez , Robert Sibley , Ming Wang , Tiffany Turner , Catherine Brennan
- 申请人地址： US CT West Haven
- 专利权人： Bayer Pharmaceuticals Corporation
- 当前专利权人： Bayer Pharmaceuticals Corporation
- 当前专利权人地址： US CT West Haven
- 代理机构： Millen, White, Zelano & Branigan, P.C.
- 主分类号： A61K31/40
- IPC分类号： A61K31/40 ; A61K31/44 ; A61K31/535 ; C07D333/22 ; C07D233/61
摘要：
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.
公开/授权文献
信息查询
